Answers are grounded in this paper and cite their sources.
1) muscle aPKCs are activated at relatively low, presumably physiological, as well as higher supraphysiological, insulin concentrations; 2) aPKC activation is defective in muscles of high-fat-fed and STZ-diabetic rats; and 3) defective aPKC activation in these states is at least partly due to impaired responsiveness to PI-3,4,5-(PO(4))(3), apparently at activation steps distal to PDK-1-dependent loop phosphorylation.
No takes yet. Share an insight, caveat, or question.
Kanoh et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: